Sophisticated and simple
Overview Single-time-point (STP) dosimetry has emerged as a practical alternative to traditional multi-time-point approaches for radiopharmaceutical therapies. In metastatic castration-resistant prostate cancer (mCRPC) treated with…
Overview Single time-point (STP) dosimetry is gaining traction in the management of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177 labeled PSMA (177Lu-PSMA). This approach…